Dow Down0.56% Nasdaq Down0.79%

Vanda Pharmaceuticals, Inc. (VNDA)

-NasdaqGM
8.32 Down 0.09(1.07%) May 4, 4:00PM EDT
|After Hours : 8.32 0.00 (0.00%) May 4, 4:46PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingDec 31, 2015Dec 31, 2014Dec 31, 2013
Total Revenue 109,925   50,157   33,879  
Cost of Revenue23,462  1,583   -  
Gross Profit 86,463   48,574   33,879  
Operating Expenses
Research Development29,145  19,230  28,502  
Selling General and Administrative84,531  84,644  25,082  
Non Recurring -   -   -  
Others12,972  2,254  1,495  
Total Operating Expenses -   -   -  
Operating Income or Loss (40,185) 20,062   (21,200)
Income from Continuing Operations
Total Other Income/Expenses Net320  77,740  145  
Earnings Before Interest And Taxes(39,865)97,802  (21,055)
Interest Expense -   -   -  
Income Before Tax(39,865)97,802  (21,055)
Income Tax Expense -   -   -  
Minority Interest -   -   -  
Net Income From Continuing Ops(39,865)97,802  (21,055)
Non-recurring Events
Discontinued Operations -   -   -  
Extraordinary Items -   -   -  
Effect Of Accounting Changes -   -   -  
Other Items -   -   -  
Net Income (39,865) 20,186   (21,055)
Preferred Stock And Other Adjustments -   -   -  
Net Income Applicable To Common Shares (39,865) 20,186   (21,055)

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.